Clinical Trial Update: To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for HSK16149 capsule assessing efficacy and safety in diabetic peripheral neuropathic pain in Chinese patients (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathic Pain

Drugs mentioned

• HSK16149

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Diabetic Peripheral Neuropathic Pain | Phase 2, Phase 3 | Status: UNKNOWN